A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction
Clinical trial NCT05309135 · COMPLETED
Trial details
- NCT number
- NCT05309135
- Sponsor
- Aurion Biotech
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-24
- Primary completion
- 2023-03-09
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.